Skip to Content
Merck
  • Kinetics of competitive drug action at 5-hydroxytryptamine2 receptors in isolated rabbit aorta.

Kinetics of competitive drug action at 5-hydroxytryptamine2 receptors in isolated rabbit aorta.

The Journal of pharmacology and experimental therapeutics (1987-07-01)
B M Clancy, R Osman, S Maayani
ABSTRACT

The kinetics of agonist and antagonist interactions with the 5-hydroxytryptamine2 receptor were studied in the isolated rabbit aorta by following the antagonist-induced decrease in the steady-state response to an agonist. A model describing the competitive drug-receptor interactions was fitted to the data and yielded estimates of the association and dissociation rate constants of the agonist and the antagonist. A high concentration of the agonist ([agonist] much greater than KA) was used to reduce the influence of antagonist diffusion to the receptor upon the onset of antagonism. The effect of a diffusion barrier was evaluated by comparing the kinetics of drug competition in the absence and in the presence of the adventitia. The rate constants of the high-affinity antagonists spiperone, methysergide or ketanserin were similar in the absence and in the presence of the adventitia. In contrast, the rate constants of the low affinity antagonist 5-methoxygramine were reduced almost 5-fold in the presence of the adventitia. This observation may be explained by the large partition coefficients of the high-affinity antagonists as compared to the relatively low partition coefficient of 5-methoxygramine. The ratios of the estimated rate constants (k-x/kx) are in good agreement with the dissociation constants of the drugs determined with steady-state methods. In addition the results suggest that the association rate constant is a primary determinant of drug affinity for the receptor. The kinetic rate constants of the high-affinity antagonists measured in this preparation are similar to those previously reported in high-affinity binding studies. We conclude that the kinetic parameters obtained in our experiments reflect primarily the molecular interactions of these drugs with the receptor.